ABEO
Abeona Therapeutics Inc
NASDAQ: ABEO · HEALTHCARE · BIOTECHNOLOGY
$5.34
-0.37% today
Updated 2026-04-29
Market cap
$303.75M
P/E ratio
5.29
P/S ratio
52.19x
EPS (TTM)
$1.01
Dividend yield
—
52W range
$4 – $8
Volume
1.2M
Abeona Therapeutics Inc (ABEO) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$5.34
12-Month target
$4.42
2030 Target
—
Intrinsic (DCF)
$27.73
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 5.29x (capped 25x) · Margin: 1,223.00%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.